Immune cell signaling in lupus

被引:61
作者
Tsokos, GC
Wong, HK
Enyedy, EJ
Nambiar, MP
机构
[1] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA
[2] Uniformed Serv Univ Hlth Sci, Dept Med, Silver Spring, MD USA
关键词
D O I
10.1097/00002281-200009000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The fate of the lymphocyte is determined by integration of signals delivered after the binding of antigen to the surface antigen receptor, signals delivered by cytokines that bind to their surface receptors, and signals initiated after the engagement of other surface receptors, known as costimulatory molecules. The summation of this input determines whether the immune cell will become stimulated, ignore the signal (anergy), or die (apoptosis). Antigen-receptor signaling events are abnormal in lupus lymphocytes, manifested by increased calcium responses and hyperphosphorylation of several cytosolic protein substrates. Further down, at the gene transcription level, the activity of the nuclear factor kappa B is decreased. These events are underwritten by defective T cell receptor zeta chain expression, overexpression of the gamma chain of the Fc epsilon RI that functions as an alternate of zeta chain, and decreased p65 -Rel A protein that is responsible for the inducible NF kappa B activity, Accumulated research data have enabled us to begin deciphering the molecular basis of the abnormal lupus lymphocyte and may lead to the development of new medicinal treatments for lupus. (C) 2000 Lippincoit Williams & Wilkins, Inc.
引用
收藏
页码:355 / 363
页数:9
相关论文
共 61 条
[51]   TCRζ chain lacking exon 7 in two patients with systemic lupus erythematosus [J].
Takeuchi, T ;
Tsuzaka, K ;
Pang, M ;
Amano, K ;
Koide, J ;
Abe, T .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (07) :911-921
[52]   ACTIVATION-INDUCED PROTEOLYSIS OF THE CYTOPLASMIC DOMAIN OF ZETA IN T-CELL RECEPTORS AND FC-RECEPTORS [J].
TAUPIN, JL ;
ANDERSON, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) :3000-3004
[53]   CHARACTERIZATION OF IN-VIVO MUTATED T-CELL CLONES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
THEOCHARIS, S ;
SFIKAKIS, PP ;
LIPNICK, RN ;
KLIPPLE, GL ;
STEINBERG, AD ;
TSOKOS, GC .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 74 (02) :135-142
[54]  
TSOKOS GC, 1983, J IMMUNOL, V131, P1797
[55]   Immune cell signaling defects in lupus: activation, anergy and death [J].
Tsokos, GC ;
Liossis, SNC .
IMMUNOLOGY TODAY, 1999, 20 (03) :119-124
[56]  
TSOKOS GC, 1982, CLIN EXP IMMUNOL, V50, P239
[57]  
VASSILOPOULOS D, 1995, J IMMUNOL, V155, P2269
[58]   MOLECULAR-CLONING AND CHROMOSOMAL LOCALIZATION OF THE HUMAN T-CELL RECEPTOR ZETA-CHAIN - DISTINCTION FROM THE MOLECULAR CD3 COMPLEX [J].
WEISSMAN, AM ;
HOU, D ;
ORLOFF, DG ;
MODI, WS ;
SEUANEZ, H ;
OBRIEN, SJ ;
KLAUSNER, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (24) :9709-9713
[59]  
Wong HK, 1999, J IMMUNOL, V163, P1682
[60]  
Yamazaki T, 1997, J IMMUNOL, V158, P1634